Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications.

J Mark Access Health Policy · 2014 · PMC4865781 · PMID 27226839

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

In Europe, there is also a clear trend for reformulation cases being developed by the same company (77.1% of cases), with most of those cases being submitted through national procedure in all of the countries.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.